GMED
Globus Medical Inc Class A · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website globusmedical.com
- Employees(FY) 2600
- ISIN US3795772082
Performance
+1.22%
1W
+1.4%
1M
+28.08%
3M
+27.7%
6M
+27.7%
YTD
+17.07%
1Y
Profile
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales presence, as well as its hip and knee products primarily through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Investment Analysis Report: GMED
Overview
In this investment analysis report, we will delve into the financial statements of GMED, a company operating in the Health Technology sector with a market capitalization of $6.21 billion. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operati...
Technical Analysis of GMED 2024-05-31
Overview:
In analyzing the technical indicators for GMED over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed deci...
Recent News & Updates
- 2023-08-03 04:30
Globus Medical Reports Second Quarter 2023 Results(Yahoo Finance)
- 2023-07-30 23:13
Globus Medical (GMED) Gains on Innovation, Strategic Deal(Yahoo Finance)
- 2023-07-30 20:30
- 2023-07-25 23:40
ITGR or GMED: Which Is the Better Value Stock Right Now?(Yahoo Finance)
- 2023-07-16 21:06
Here's Why You Should Retain Globus Medical (GMED) Stock Now(Yahoo Finance)
- 2023-07-13 04:30
- 2023-07-13 01:55
CFO of the Year Awards 2023: Keith Pfeil, Globus Medical(Yahoo Finance)
- 2023-06-28 17:25
- 2023-06-21 08:00
GMED: What does Argus have to say about GMED?(Yahoo Finance)
- 2023-06-12 22:15
- 2023-05-25 19:50
Here's Why You Should Retain Globus Medical (GMED) Stock Now(Yahoo Finance)
- 2023-05-20 22:18
Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?(Yahoo Finance)
- 2023-05-16 02:35
- 2023-05-15 04:30
- 2023-05-05 01:23
- 2023-05-04 20:16
Q1 2023 Globus Medical Inc Earnings Call(Yahoo Finance)
- 2023-05-04 12:30
Globus Medical (GMED) Q1 2023 Earnings Call Transcript(Yahoo Finance)
- 2023-05-04 07:25
- 2023-05-04 04:15
Globus Medical Reports First Quarter 2023 Results(Yahoo Finance)
- 2023-05-03 06:45
Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates(Yahoo Finance)
- 2023-04-27 07:08
- 2023-04-26 23:30
- 2023-04-26 08:00
GMED: What does Argus have to say about GMED?(Yahoo Finance)
- 2023-04-23 18:48
- 2023-04-19 05:15
- 2023-04-17 07:22
7 Stocks to Buy with Bulletproof Balance Sheets(Yahoo Finance)
- 2023-04-17 01:57
- 2023-04-14 02:21
- 2023-04-13 22:31
Globus' (GMED) NUVA Buyout Seems Strategic, Cost Woe Stays(Yahoo Finance)
- 2023-03-27 00:27